Cargando…
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2
The Omicron variant (B.529) of COVID-19 caused disease outbreaks worldwide because of its contagious and diverse mutations. To reduce these outbreaks, therapeutic drugs and adjuvant vaccines have been applied for the treatment of the disease. However, these drugs have not shown high efficacy in redu...
Autores principales: | Begum, Rahima, Mamun-Or-Rashid, A. N. M., Lucy, Tanzima Tarannum, Pramanik, Md. Kamruzzaman, Sil, Bijon Kumar, Mukerjee, Nobendu, Tagde, Priti, Yagi, Masayuki, Yonei, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609612/ https://www.ncbi.nlm.nih.gov/pubmed/36296527 http://dx.doi.org/10.3390/molecules27206934 |
Ejemplares similares
-
Inhibitory Effects of Astaxanthin on CML-HSA-Induced Inflammatory and RANKL-Induced Osteoclastogenic Gene Expression in RAW 264.7 Cells
por: Mamun-Or-Rashid, A. N. M., et al.
Publicado: (2021) -
Serial Passaging of RAW 264.7 Cells Modulates Intracellular AGE Formation and Downregulates RANKL-Induced In Vitro Osteoclastogenesis
por: Lucy, Tanzima Tarannum, et al.
Publicado: (2022) -
Staphylococcus aureus Biofilm Inhibiting Activity of Advanced Glycation Endproduct Crosslink Breaking and Glycation Inhibiting Compounds
por: Haasbroek, Kyle, et al.
Publicado: (2022) -
Omicron with threatened antagonistic consequences and are convoyed by new fangled risks – Correspondence
por: Mukerjee, Nobendu, et al.
Publicado: (2022) -
Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
por: Akash, Shopnil, et al.
Publicado: (2023)